Australia Swine Vaccines Market Size & Outlook, 2023-2030

The swine vaccines market in Australia is expected to reach a projected revenue of US$ 71.1 million by 2030. A compound annual growth rate of 5.9% is expected of Australia swine vaccines market from 2024 to 2030.
Revenue, 2023 (US$M)
$47.6
Forecast, 2030 (US$M)
$71.1
CAGR, 2024 - 2030
5.9%
Report Coverage
Australia

Australia swine vaccines market highlights

  • The Australia swine vaccines market generated a revenue of USD 47.6 million in 2023 and is expected to reach USD 71.1 million by 2030.
  • The Australia market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
  • In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
  • Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.


Swine vaccines market data book summary

Market revenue in 2023USD 47.6 million
Market revenue in 2030USD 71.1 million
Growth rate5.9% (CAGR from 2023 to 2030)
Largest segmentInactivated (killed)
Fastest growing segmentOther Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationModified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
Key market players worldwideMerck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA


Other key industry trends

  • In terms of revenue, Australia accounted for 2.9% of the global swine vaccines market in 2023.
  • Country-wise, China is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China swine vaccines market is projected to lead the regional market in terms of revenue in 2030.
  • South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 14.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Swine Vaccines Market Companies

Name Profile # Employees HQ Website

Australia swine vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.


Inactivated (killed) was the largest segment with a revenue share of 39.92% in 2023. Horizon Databook has segmented the Australia swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia swine vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia swine vaccines market databook

  • Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Australia swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia swine vaccines market size, by vaccine type, 2018-2030 (US$M)

Australia Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)

Australia swine vaccines market size, by vaccine type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more